Paul Soloway

Title: Paul Soloway: Innovator in Epigenetic and Molecular Analysis

Introduction

Paul Soloway is a distinguished inventor based in Ithaca, NY (US), known for his significant contributions to the fields of epigenetic and molecular analysis. With a total of four patents to his name, Soloway has developed innovative methods and devices that enhance the understanding of genetic materials.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Device and methods for epigenetic analysis." This invention provides methods and devices for single object detection, enabling the identification of a plurality of epigenetic markers on genetic material or chromatin. The invention allows for the characterization of genetic material flowing through a channel in a continuous body of fluid, based on the detection of one or more properties of the genetic material. This advancement facilitates genome-wide, high-throughput epigenetic analysis, overcoming limitations common to bulk analysis techniques.

Another notable patent is "Device and methods for molecular analysis." This invention outlines systems and methods for high-speed sorting of objects in a continuous body of fluid. The objects can be analyzed within one or more interrogation volumes, allowing for simultaneous or time-correlated measurement of their properties. A processor interprets these properties and directs the objects to various downstream flow paths. The sorting process can be repeated, creating a network of sorting events based on multiple properties of the objects.

Career Highlights

Paul Soloway is affiliated with Cornell University, where he continues to push the boundaries of research in his field. His work has garnered attention for its potential applications in various scientific and medical domains.

Collaborations

Soloway has collaborated with notable colleagues, including Harold G. Craighead and Benjamin Ryan Cipriany, contributing to the advancement of research in epigenetics and molecular analysis.

Conclusion

Paul Soloway's innovative work in epigenetic and molecular analysis has made a significant impact on the scientific community. His patents reflect a commitment to advancing technology in genetic research, paving the way for future discoveries.